EMP2 and acute lymphoblastic leukemia: Based on the BM sample of healthy persons and ALL patients from TCGA, we found that, compared to healthy BM, in ALL, the gene expression level of LILRA1, NRGN, MT-ND6, EMP2, and IGHM were significantly decreased (Figure 4C).